Bar-Or A, Cross AH, Cunningham AL, Hyvert Y, et al. Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton's tyrosine kinase inhibitor. Mult Scler 2023 Aug 25:13524585231192460. doi: 10.1177/13524585231192460.
PMID: 37626477